Table 2.
Variables | TdIF1 expression | Total | Χ 2 | P value | ||
---|---|---|---|---|---|---|
High | Low | |||||
Age (year) | 1.298 | 0.254 | ||||
≤60 | 24 | 17 | 41 | |||
>60 | 35 | 15 | 50 | |||
Sex | 1.298 | 0.254 | ||||
Female | 24 | 17 | 41 | |||
Male | 35 | 15 | 50 | |||
TNM stage | 3.613 | 0.057 | ||||
I/II | 24 | 21 | 45 | |||
III/IV | 30 | 11 | 41 | |||
null | 5 | |||||
T stage | 5.129 | 0.024* | ||||
N0 | 20 | 18 | 38 | |||
N1/N2/N3 | 28 | 8 | 36 | |||
null | 17 | |||||
M stage | 0.558 | 0.455 | ||||
M0 | 57 | 32 | 89 | |||
M1 | 1 | 0 | 1 | |||
null |
Correlation analysis between TdIF1 expression and clinical indicators of lung adenocarcinoma patients was conducted using chi-square test and spearman analysis. P values <0.05 were considered statistically significant
TNM stage tumor lymph node and metastasis stage, T tumor, N lymph node, M metastasis